Lung Neuroendocrine Tumor — Trials

Lung Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03879694	Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors	completed	Phase 1	19	Roswell Park Cancer InstituteOTHER	1	Feb 6, 2026	clinicaltrials
NCT01204476	Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma	completed	Phase 1	27	National Cancer Institute (NCI)NIH	1	Jul 15, 2016	clinicaltrials
NCT01548482	Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	completed	Phase 1	21	National Cancer Institute (NCI)NIH	1	Oct 6, 2015	clinicaltrials
NCT00004074

Data updated 22 days agoSource updated Feb 6, 2026source: clinicaltrials